Catherine Novack
Stock Analyst at Jones Trading
(0.65)
# 4,001
Out of 4,981 analysts
20
Total ratings
29.41%
Success rate
-13.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $12.86 | +133.28% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $6.04 | +380.13% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.37 | +1,536.21% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.59 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $54.48 | -17.39% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.00 | +450.00% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $31.35 | +314.67% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.71 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.97 | +129.56% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.96 | +253.54% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.04 | +537.25% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.47 | +33.87% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.85 | +673.29% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.91 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.57 | +28,198.50% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $12.86
Upside: +133.28%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $6.04
Upside: +380.13%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.37
Upside: +1,536.21%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.59
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $54.48
Upside: -17.39%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.00
Upside: +450.00%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $31.35
Upside: +314.67%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.71
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.97
Upside: +129.56%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.96
Upside: +253.54%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.04
Upside: +537.25%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $7.47
Upside: +33.87%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $2.85
Upside: +673.29%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.91
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.57
Upside: +28,198.50%